Allscripts Healthcare Solutions Inc (MDRX) Stock Forecast & Predictions

Allscripts Healthcare Solutions Inc MDRX: $16.45

222 Merchandise Mart Plz Ste 2024, Chicago, Illinois, US. | Sector: Professional, Scientific, and Technical Services | Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET) | Web: https://www.allscripts.com/

  • Market Cap$2.24B
  • Change (52 Weeks)158.02%
  • Low (52 Weeks)$5.28
  • Allscripts Healthcare Solutions Inc (MDRX) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 18.75% are on Buy, 31.25% on Sell, and 50.00% Neutral.

    According to the market data, Allscripts Healthcare Solutions Inc (MDRX) stock price is $16.45 and the 52 weeks low is $5.28, which means the Allscripts Healthcare Solutions Inc stock price is up 158.02% in the last 12 months.

    Allscripts Healthcare Solutions Inc (MDRX) Stock Price has been Trending Strongly with an ADX reading of 38.63 as per the Weekly Chart.

    A Upward trend indicates that Allscripts Healthcare Solutions Inc (MDRX) Stock Price may keep going up, with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors).

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 18.75% are indicating that MDRX Stock price might rise further, 31.25% indicating that MDRX Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall MDRX stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Allscripts Healthcare Solutions Inc (MDRX) Stock Forecast By Analysts


    On Hold
    Analysts Recommendations for Allscripts Healthcare Solutions Inc (MDRX) is based on 23 Institutional Analyst Ratings where 21.74% are on Strong Buy, 21.74% on Moderate Buy, 47.83% remains on Hold, 0.00% are on Moderate Sell and 8.70% are on Strong Sell.

    Out of 23 Institutional Analysts, majority recommended MDRX stock as On Hold. This means investors are recommended to hold their existing positions if any, otherwise, the recommendation is neither to buy nor sell at this stage. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Allscripts Healthcare Solutions Inc.

    Allscripts Healthcare Solutions Inc (MDRX) Stock Price Prediction By Analysts


    HighLowAverage
    $21.00$11.11$15.57
    $15.575.34% Downside
    Updated: 2021-04-22 00:00:00

    The Average Price target for MDRX set by the institutional analysts is $15.57 where High Estimate is $21.00, Median $15.3 and Low $11.11.

    The average price target for MDRX by Institutional Analysts is $15.57, which is 5.34% Downside from the current price. So according to the Institutional Analysts, MDRX Stock might be a bit overvalued at this stage and there’s potential for downside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Allscripts Healthcare Solutions Inc (MDRX) Stock Forecast Based on Investor Sentiment


    Very Positive

    Based on 388,226 investor portfolio.

    Our algorithm has analysed 388,226 investor portfolio with MDRX stock holdings and found that 99.50% of them are bullish. Which means the Investor Sentiment is mostly Very Positive.

    This shows most investors are very optimistic about MDRX and holding their positions hoping for a further rise in the stock price and more profit.

    Allscripts Healthcare Solutions Inc (MDRX) Stock Forecast Based on News Sentiment


    Bullish
    Based on 4 articles published Last Week, where 100.00% are Bullish and 0.00% are Bearish.

    According to the news articles published last week, most journalists and bloggers talked positively about MDRX, it shows that Allscripts Healthcare Solutions Inc had a 100.00% positive news coverage.

    Positive news coverage usually affects short-term price of a stock, so this positive coverage provides an indication that MDRX stock price may surge in the next few weeks.

    Allscripts Healthcare Solutions Inc (MDRX) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    Argus ResearchHoldDowngraded
    SVB LeerinkMarket PerformMaintained
    B of A SecuritiesBuyMaintained
    BairdNeutralDowngraded
    SVB LeerinkMarket PerformMaintained
    Cantor FitzgeraldNeutralMaintained
    JP MorganNeutralMaintained
    Morgan StanleyUnderweightMaintained
    RBC CapitalOutperformMaintained
    SVB LeerinkMarket PerformMaintained
    Cantor FitzgeraldNeutralMaintained
    Goldman SachsSellDowngraded
    SunTrust Robinson HumphreyHoldMaintained
    Morgan StanleyUnderweightMaintained
    SVB LeerinkMarket PerformMaintained
    Cantor FitzgeraldNeutralReiterated
    JefferiesHoldDowngraded
    RBC CapitalOutperformInitiated
    SunTrust Robinson HumphreyHoldMaintained
    Deutsche BankHoldMaintained
    CFRAStrong SellMaintained
    Cantor FitzgeraldNeutralReiterated
    BairdOutperformMaintained
    UBSNeutralInitiated
    Deutsche BankHoldInitiated
    CitigroupNeutralDowngraded
    KeyBancSector WeightDowngraded
    CitigroupNeutralDowngraded
    KeyBancOverweightUpgraded
    ArgusHoldDowngraded
    JP MorganNeutralDowngraded
    CitigroupBuyMaintained
    Cantor FitzgeraldNeutralDowngraded
    Bank of AmericaBuyMaintained
    BairdOutperformMaintained
    Canaccord GenuityBuyMaintained
    Bank of AmericaBuyMaintained
    Evercore ISI GroupOutperformInitiated
    SunTrust Robinson HumphreyHoldDowngraded
    BairdOutperformMaintained
    RBC CapitalOutperformInitiated
    Cowen & Co.OutperformUpgraded
    Cantor FitzgeraldOverweightUpgraded
    Morgan StanleyUnderweightMaintained
    CitigroupNeutralMaintained
    Leerink SwannMarket PerformDowngraded
    Bank of AmericaNeutralInitiated
    Wells FargoOutperformUpgraded
    DoughertyBuyUpgraded
    Cantor FitzgeraldNeutralInitiated
    Morgan StanleyUnderweightDowngraded
    DoughertyNeutralInitiated
    Deutsche BankHoldDowngraded
    UBSBuyInitiated
    Cowen & Co.Market PerformDowngraded
    Leerink SwannOutperformUpgraded
    Goldman SachsNeutralMaintained
    Deutsche BankBuyMaintained
    CitigroupNeutralMaintained
    Morgan StanleyOverweightUpgraded
    SunTrust Robinson HumphreyBuyMaintained
    Deutsche BankBuyMaintained
    BarclaysEqual-WeightMaintained
    RBC CapitalOutperformUpgraded
    Raymond JamesMarket PerformDowngraded
    Leerink SwannMarket PerformMaintained
    Deutsche BankBuyMaintained
    Canaccord GenuityBuyInitiated
    ArgusBuyUpgraded
    OppenheimerPerformInitiated
    PiperJaffrayNeutralUpgraded
    Stifel NicolausHoldInitiated
    BairdOutperformInitiated
    Leerink SwannMarket PerformDowngraded
    BarclaysEqual-WeightMaintained
    JP MorganOverweightMaintained
    RBC CapitalSector PerformDowngraded
    Evercore ISI GroupHoldDowngraded
    Credit SuisseOutperformMaintained
    CitigroupNeutralMaintained
    Credit SuisseOutperformMaintained
    Raymond JamesOutperformMaintained
    JP MorganOverweightMaintained
    JefferiesBuyUpgraded
    ISI GroupStrong BuyUpgraded
    TopekaHoldInitiated
    Wells FargoMarket PerformMaintained
    SunTrust Robinson HumphreyBuyMaintained
    PiperJaffrayUnderweightMaintained
    OppenheimerMarket PerformMaintained
    Leerink SwannOutperformMaintained
    JP MorganOverweightMaintained
    ISI GroupBuyUpgraded
    FBR CapitalMarket PerformMaintained
    CitigroupHoldMaintained
    BarclaysEqual-WeightMaintained
    BairdOutperformMaintained
    B. Riley FBRNeutralMaintained
    Raymond JamesOutperformMaintained
    SunTrust Robinson HumphreyBuyInitiated
    BarclaysEqual-WeightInitiated
    Morgan StanleyOverweightMaintained
    CitigroupNeutralInitiated
    Maxim GroupBuyUpgraded
    B. Riley FBRNeutralUpgraded
    Morgan StanleyOverweightMaintained
    B. Riley FBRSellDowngraded
    JP MorganOverweightInitiated
    Deutsche BankBuyInitiated
    Leerink SwannOutperformUpgraded
    Stephens & Co.Equal-WeightInitiated
    KeyBancHoldInitiated
    ISI GroupNeutralDowngraded
    Sterne AgeeBuyInitiated
    JefferiesHoldMaintained
    Raymond JamesOutperformDowngraded
    CitigroupBuyUpgraded
    Morgan StanleyOverweightUpgraded
    Maxim GroupHoldDowngraded
    B. Riley FBRNeutralInitiated
    Credit SuisseOutperformUpgraded
    JefferiesHoldMaintained
    ISI GroupBuyMaintained
    Raymond JamesStrong BuyUpgraded
    Avondale PartnersUpgraded
    JefferiesHoldMaintained
    ISI GroupOverweightMaintained
    PiperJaffrayUnderweightDowngraded
    JefferiesHoldMaintained
    CitigroupNeutralMaintained
    Sterne AgeeBuyMaintained
    ISI GRoupOverweightUpgraded
    Cowen & Co.OutperformUpgraded
    PiperJaffrayNeutralMaintained
    JP MorganOverweightUpgraded
    CitigroupNeutralMaintained
    ISI GroupMarket WeightInitiated
    UBSNeutralDowngraded
    PiperJaffrayNeutralDowngraded
    OppenheimerPerformDowngraded
    JefferiesHoldDowngraded
    Goldman SachsNeutralMaintained
    Credit SuisseNeutralDowngraded
    CitigroupNeutralDowngraded
    AurigaHoldDowngraded
    JP MorganNeutralDowngraded
    Credit SuisseOutperformInitiated
    AurigaBuyMaintained

    Allscripts Healthcare Solutions Inc (MDRX) Stock Earning Per Share (EPS) Forecast / Estimate


    $0.175
    The average consensus EPS for MDRX is $0.175 with a high estimate of $0.221 and Low of $0.147 for the period 2021-06-30 and based on 17 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $0.2$0.193106399999999982020-09-30


    The latest average Earning Per Share Estimate for Allscripts Healthcare Solutions Inc is $0.17, which is lower than MDRX's last EPS, $0.20. This means that Analysts are expecting Allscripts Healthcare Solutions Inc to report lower earnings. This can drive share prices lower since the investors have negative sentiment about market performance of Allscripts Healthcare Solutions Inc.

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $0.2$0.193106399999999982020-09-30
    $0.18$0.12298142020-06-30
    $0.09$0.151472020-03-31
    $0.17$0.18643562019-12-31
    $0.17$0.170340000000000022019-09-30
    $0.17$0.16502582019-06-30
    $0.16$0.144952199999999982019-03-31
    $0.2$0.214709999999999982018-12-31
    $0.18$0.2020112018-09-30
    $0.18$0.18301862018-06-30
    $0.16$0.17562362018-03-31
    $0.18$0.18593582017-12-31
    $0.16$0.161588400000000022017-09-30
    $0.15$0.152112600000000012017-06-30
    $0.13$0.13491542017-03-31
    $0.14$0.15521342016-12-31
    $0.14$0.14960342016-09-30
    $0.14$0.14011742016-06-30
    $0.13$0.12579662016-03-31
    $0.13$0.13083542015-12-31
    $0.13$0.11798342015-09-30
    $0.12$0.107671200000000012015-06-30
    $0.08$0.092952600000000012015-03-31
    $0.09$0.09430922014-12-31
    $0.06$0.1002662014-09-30
    $0.09$0.08968862014-06-30
    $0.07$0.072603599999999992014-03-31
    $0.08$0.07756082013-12-31
    $0.05$0.078234000000000012013-09-30
    $0.05$0.099960000000000012013-06-30
    $0.09$0.14282013-03-31
    $0.16$0.207396600000000012012-12-31
    $0.23$0.227462012-09-30
    $0.16$0.181662000000000022012-06-30
    $0.12$0.243831000000000022012-03-31
    $0.25$0.2552011-12-31
    $0.25$0.2290412011-09-30
    $0.22$0.21905522011-06-30
    $0.21$0.20345942011-03-31
    $0.2$0.186152010-12-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).